Outset Medical, Inc. Q3 2025 Earnings Recap

Outset Medical, Inc. reported third-quarter revenue of $29.4 million, reflecting 3% growth year-over-year, while navigating challenges in sales execution and timing of deal closures.

Key Takeaways

• Sales opportunities expected to close in Q3 have been postponed to Q4 and into 2026, highlighting complexities in securing large enterprise-wide contracts.
• Tableau console sales grew 8%, contributing to a significant increase in average deal size by over 20%, indicating strong customer demand for insourcing dialysis.
• Non-GAAP gross margin improved to 39.9%, with ongoing improvements expected to reach the 50% target, fueled by efficient expense management and increasing product gross margins.
• Leadership transition in the sales department may create temporary disruption but is aimed at strengthening commercial execution moving forward.
• Recurring revenue from Tableau consumables and services reached $21.1 million, with improvements in order patterns anticipated to stabilize in the coming quarters.